Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in neuromuscular blocking agents.

R R Bartkowski1

  • 1Department of Anesthesiology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|August 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapacuronium: first experience in clinical practice.

European journal of anaesthesiology. Supplement·2002
Same author

Measurement of CO2 response with the breath-by-breath automatic acquisition of the breathing pattern and occlusion pressure.

Journal of clinical monitoring·1995
Same author

Intraoperative hemodynamic, renin, and catecholamine responses after prophylactic and intraoperative administration of intravenous enalaprilat.

Anesthesia and analgesia·1995
Same author

Rocuronium onset of action: a comparison with atracurium and vecuronium.

Anesthesia and analgesia·1993
Same author

The pharmacokinetics of droperidol in anesthetized children.

Anesthesia and analgesia·1993
Same author

A comparison of desflurane and isoflurane in prolonged surgery.

Journal of clinical anesthesia·1993

Newer neuromuscular blocking agents aim for fewer side effects and better control than succinylcholine. Development focuses on rapid onset and short duration, improving surgical procedures and patient monitoring.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Neuromuscular blocking agents are crucial in anesthesia.
  • Succinylcholine, while effective, has limitations regarding adverse effects and control.
  • Development aims to create agents with improved safety and efficacy profiles.

Purpose of the Study:

  • To discuss the driving factors behind the development of modern neuromuscular blocking agents.
  • To highlight the goals of achieving faster onset and greater control with fewer adverse effects.
  • To review specific agents and their characteristics in relation to these goals.

Main Methods:

  • Review of existing literature on neuromuscular blocking agents.
  • Discussion of pharmacokinetic and pharmacodynamic properties influencing onset and duration.

Related Experiment Videos

  • Comparison of clinical data for agents like rocuronium and rapacuronium.

    • Main Results:

    • Newer agents focus on rapid, organ-independent metabolism or rapid distribution for predictable duration and onset.
    • Low-potency agents like rocuronium and rapacuronium demonstrate faster onset compared to older agents.
    • Rapacuronium shows a very rapid onset and short duration, suitable for specific procedures.

    Conclusions:

    • Advances in neuromuscular blocking agents offer faster onset and greater control.
    • Nondepolarizing relaxants are evolving to provide improved options for anesthesia.
    • The development trend favors agents with predictable, controllable durations and rapid onset, reducing adverse events.